1012633

Salbutamol hemisulfate salt

United States Pharmacopeia (USP) Reference Standard

• Sinónimos: Salbutamol hemisulfate salt, α₁-[(tert-Butylamino)methyl]-4-hydroxy-1,3-benzenedimethanol hemisulfate salt, Albuterol sulfate
• Fórmula empírica (notación de Hill): C₁₃H₂₁NO₃ · 0.5H₂SO₄
• Número de CAS: 51022-70-9
• Peso molecular: 288.35
• MDL number: MFCD00055200
• UNSPSC Code: 41116107
• PubChem Substance ID: 329748947
• NACRES: NA.24

Propiedades

• grade: pharmaceutical primary standard
• API family: salbutamol, albuterol
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• format: neat
• SMILES string: OS(O)(=O)=O.CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.CC(C)(C)NCC(O)c2ccc(O)c(CO)c2
• InChI: 1S/2C13H21NO3.H2O4S/c2*1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;1-5(2,3)4/h2*4-6,12,14-17H,7-8H2,1-3H3;(H2,1,2,3,4)
• InChI key: BNPSSFBOAGDEEL-UHFFFAOYSA-N
• Gene Information: human ... ADRB2(154)

Descripción

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

• Albuterol sulfate in pediatric pharmacology: A study evaluated the medication management for children with complex medical conditions using Albuterol sulfate among other medications. This research highlights its critical role in pediatric respiratory therapies, emphasizing its safety and efficacy (Quinn et al., 2024).


• Nebulizer comparison in COPD: Albuterol sulfate′s delivery via different nebulizers was analyzed for effectiveness in treating chronic obstructive pulmonary disease (COPD). The study provides valuable insights into its application in respiratory care, particularly in optimizing delivery methods for enhanced patient outcomes (Feng et al., 2024).


• siRNA delivery in lung therapy: The potential of β(2)-agonists including Albuterol sulfate was explored as adjuvants in siRNA delivery for treating pulmonary diseases. This innovative approach underscores its utility beyond conventional bronchodilation, marking significant advancements in respiratory therapy research (Merckx et al., 2024).

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Información de seguridad

• pictograms: GHS08,GHS07
• signalword: Warning
• hcodes: H317,H351,H361fd
• pcodes: P202 - P261 - P272 - P280 - P302 + P352 - P308 + P313
• Hazard Classifications: Carc. 2 - Repr. 2 - Skin Sens. 1
• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 2
• flash_point_f: Not applicable
• flash_point_c: Not applicable